When it comes to frequently diagnosed cancers in women, there are two types that are the most common: cervical and ovarian ...

An NDA has been accepted by the FDA for the combination of avutometinib and defactinib in KRAS-mutated recurrent low-grade ...

The FDA accepts Verastem's NDA for the accelerated approval of avutometinib to treat recurrent KRAS mutant ovarian cancer under priority review. The stock rises 41%.

Get here the official CBSE Class 12 Biology practical syllabus along with the marking and evaluation scheme. Know how to get ...

Time for some extremely good news: the cures for catastrophic diseases like cancer, Parkinson’s, heart disease and HIV are ...

The National Eligibility cum Entrance Test (NEET) is a competitive medical entrance examination in India for admission to undergraduate medical courses such as MBBS and BDS. Biology is often regarded ...

Verastem Oncology announced that the FDA has accepted for review the New Drug Application, NDA, under the accelerated approval pathway for avutometinib, an ...

Stenoparib is under clinical development by Allarity Therapeutics and currently in Phase II for Metastatic Ovarian Cancer.

Surufatinib is under clinical development by Hutchison MediPharma and currently in Phase II for Epithelial Ovarian Cancer.

Ovarian cysts are usually harmless but treatments may be needed to manage symptoms. They will vary based on whether lifestyle changes and natural remedies can help, or whether medication or a ...

By gaining a better understanding of ovarian biology, scientists are now closer to creating functional artificial ovaries that could revolutionize fertility treatments. CAR T-Cell Therapy for ...